comparemela.com

Latest Breaking News On - Masahiro natsuaki - Page 1 : comparemela.com

Can Aspirin Be Omitted After PCI in Patients With High Bleeding Risk?

Adding aspirin to dual antiplatelet therapy after percutaneous coronary intervention did not increase bleeding risk and may protect against coronary events.

Masahiro natsuaki

Aspirin Still Needed in First Month After PCI: STOPDAPT-3

Using prasugrel (Effient) alone in the first month after PCI did not reduce bleeding risk and there was a suggestion of possible increased ischemic risk vs dual antiplatelet therapy, in a new trial.

Noord hollandMarco valgimigliMasahiro natsuakiEuropean society of cardiologyCardiocentro ticino foundationSaga universityEuropean societyErebrovascular accidentVa cerebrovascular accidentAtherosclerotic heart diseaseTherosclerotic cardiovascular diseaseOronary heart diseaseSchemic heart diseaseAntiplatelet agentNeuroendocrine tumorDrug eluting stent

No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In

Two trials read out, but generalizability is the question

North carolinaUnited statesNoord hollandDuke university medical centerMasahiro natsuakiRenato lopesYaling hanAmerican heart association college of cardiologySaga universityChinese society of cardiologyEuropean society of cardiologyEuropean societyJacqueline tamis hollandCleveland clinicAmerican heartAmerican college

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

Megan craigMasahiro natsuakiAcademic research consortiumSaga universityHot lineBleeding academic research consortiumStudy authorCute coronary syndromeDrug eluting stentMyocardial infarction

Dual-antiplatelet therapy should remain standard strategy after stent implantation, research finds

Dual-antiplatelet therapy should remain standard strategy after stent implantation, research finds
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Masahiro natsuakiAcademic research consortiumSaga universityHot lineBleeding academic research consortium

vimarsana © 2020. All Rights Reserved.